Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 34

1.

Multilaboratory testing of two-drug combinations of antifungals against Candida albicans, Candida glabrata, and Candida parapsilosis.

Chaturvedi V, Ramani R, Andes D, Diekema DJ, Pfaller MA, Ghannoum MA, Knapp C, Lockhart SR, Ostrosky-Zeichner L, Walsh TJ, Marchillo K, Messer S, Welshenbaugh AR, Bastulli C, Iqbal N, Paetznick VL, Rodriguez J, Sein T.

Antimicrob Agents Chemother. 2011 Apr;55(4):1543-8. doi: 10.1128/AAC.01510-09. Epub 2011 Jan 31.

2.

Prospective survey of (1→3)-beta-D-glucan and its relationship to invasive candidiasis in the surgical intensive care unit setting.

Mohr JF, Sims C, Paetznick V, Rodriguez J, Finkelman MA, Rex JH, Ostrosky-Zeichner L.

J Clin Microbiol. 2011 Jan;49(1):58-61. doi: 10.1128/JCM.01240-10. Epub 2010 Nov 3.

3.

Lack of correlation of 24- vs. 48-h itraconazole minimum inhibitory concentrations with microbiological and survival outcomes in a guinea pig model of disseminated candidiasis.

Odabasi Z, Paetznick VL, Rodriguez JR, Chen E, Rex JH, Leitz GJ, Ostrosky-Zeichner L.

Mycoses. 2010 Sep;53(5):438-42. doi: 10.1111/j.1439-0507.2009.01733.x. Epub 2009 Jun 4.

PMID:
19500259
4.

Activity of anidulafungin in a murine model of Candida krusei infection: evaluation of mortality and disease burden by quantitative tissue cultures and measurement of serum (1,3)-beta-D-glucan levels.

Ostrosky-Zeichner L, Paetznick VL, Rodriguez J, Chen E, Sheehan DJ.

Antimicrob Agents Chemother. 2009 Apr;53(4):1639-41. doi: 10.1128/AAC.00955-08. Epub 2009 Jan 12.

5.

Effects of serum on in vitro susceptibility testing of echinocandins.

Odabasi Z, Paetznick V, Rex JH, Ostrosky-Zeichner L.

Antimicrob Agents Chemother. 2007 Nov;51(11):4214-6. Epub 2007 Sep 4.

6.

Correlation between microdilution, E-test, and disk diffusion methods for antifungal susceptibility testing of posaconazole against Candida spp.

Sims CR, Paetznick VL, Rodriguez JR, Chen E, Ostrosky-Zeichner L.

J Clin Microbiol. 2006 Jun;44(6):2105-8.

7.

Differences in beta-glucan levels in culture supernatants of a variety of fungi.

Odabasi Z, Paetznick VL, Rodriguez JR, Chen E, McGinnis MR, Ostrosky-Zeichner L.

Med Mycol. 2006 May;44(3):267-72.

PMID:
16702107
8.

Syscan3, a kit for detection of anti-Candida antibodies for diagnosis of invasive candidiasis.

Philip A, Odabasi Z, Matiuzzi G, Paetznick VL, Tan SW, Warmington J, Rex JH, Ostrosky-Zeichner L.

J Clin Microbiol. 2005 Sep;43(9):4834-5.

9.

In vitro synergy testing of anidulafungin with itraconazole, voriconazole, and amphotericin B against Aspergillus spp. and Fusarium spp.

Philip A, Odabasi Z, Rodriguez J, Paetznick VL, Chen E, Rex JH, Ostrosky-Zeichner L.

Antimicrob Agents Chemother. 2005 Aug;49(8):3572-4.

10.

In vitro activity of anidulafungin against selected clinically important mold isolates.

Odabasi Z, Paetznick VL, Rodriguez JR, Chen E, Ostrosky-Zeichner L.

Antimicrob Agents Chemother. 2004 May;48(5):1912-5.

11.

Disk diffusion-based methods for determining Candida parapsilosis susceptibility to anidulafungin.

Odabasi Z, Paetznick V, Goldstein BP, Rex JH, Ostrosky-Zeichner L.

Antimicrob Agents Chemother. 2003 Sep;47(9):3018-20.

12.

Correlation between E-test, disk diffusion, and microdilution methods for antifungal susceptibility testing of fluconazole and voriconazole.

Matar MJ, Ostrosky-Zeichner L, Paetznick VL, Rodriguez JR, Chen E, Rex JH.

Antimicrob Agents Chemother. 2003 May;47(5):1647-51.

13.

Evaluation of a method for identification of Candida dubliniensis bloodstream isolates.

Sancak B, Rex JH, Paetznick V, Chen E, Rodriguez J.

J Clin Microbiol. 2003 Jan;41(1):489-91.

14.

In vitro activities of investigational triazoles against Fusarium species: effects of inoculum size and incubation time on broth microdilution susceptibility test results.

Paphitou NI, Ostrosky-Zeichner L, Paetznick VL, Rodriguez JR, Chen E, Rex JH.

Antimicrob Agents Chemother. 2002 Oct;46(10):3298-300.

16.

In vitro activity of nystatin compared with those of liposomal nystatin, amphotericin B, and fluconazole against clinical Candida isolates.

Arikan S, Ostrosky-Zeichner L, Lozano-Chiu M, Paetznick V, Gordon D, Wallace T, Rex JH.

J Clin Microbiol. 2002 Apr;40(4):1406-12.

17.

In vitro antifungal susceptibilities of Trichosporon species.

Paphitou NI, Ostrosky-Zeichner L, Paetznick VL, Rodriguez JR, Chen E, Rex JH.

Antimicrob Agents Chemother. 2002 Apr;46(4):1144-6.

18.

In vitro synergy of caspofungin and amphotericin B against Aspergillus and Fusarium spp.

Arikan S, Lozano-Chiu M, Paetznick V, Rex JH.

Antimicrob Agents Chemother. 2002 Jan;46(1):245-7.

19.

Differential antifungal activity of isomeric forms of nystatin.

Ostrosky-Zeichner L, Bazemore S, Paetznick VL, Rodriguez JR, Chen E, Wallace T, Cossum P, Rex JH.

Antimicrob Agents Chemother. 2001 Oct;45(10):2781-6.

20.

In vitro susceptibility testing methods for caspofungin against Aspergillus and Fusarium isolates.

Arikan S, Lozano-Chiu M, Paetznick V, Rex JH.

Antimicrob Agents Chemother. 2001 Jan;45(1):327-30.

21.
22.
23.

Disk diffusion method for determining susceptibilities of Candida spp. to MK-0991.

Lozano-Chiu M, Nelson PW, Paetznick VL, Rex JH.

J Clin Microbiol. 1999 May;37(5):1625-7.

24.

Treatment of murine fusariosis with SCH 56592.

Lozano-Chiu M, Arikan S, Paetznick VL, Anaissie EJ, Loebenberg D, Rex JH.

Antimicrob Agents Chemother. 1999 Mar;43(3):589-91.

26.

Optimizing the correlation between results of testing in vitro and therapeutic outcome in vivo for fluconazole by testing critical isolates in a murine model of invasive candidiasis.

Rex JH, Nelson PW, Paetznick VL, Lozano-Chiu M, Espinel-Ingroff A, Anaissie EJ.

Antimicrob Agents Chemother. 1998 Jan;42(1):129-34.

27.

Activity of liposomal nystatin against disseminated Aspergillus fumigatus infection in neutropenic mice.

Wallace TL, Paetznick V, Cossum PA, Lopez-Berestein G, Rex JH, Anaissie E.

Antimicrob Agents Chemother. 1997 Oct;41(10):2238-43.

28.

Microdilution antifungal susceptibility testing of Candida albicans and Cryptococcus neoformans with and without agitation: an eight-center collaborative study.

Anaissie EJ, Paetznick VL, Ensign LG, Espinel-Ingroff A, Galgiani JN, Hitchcock CA, LaRocco M, Patterson T, Pfaller MA, Rex JH, Rinaldi MG.

Antimicrob Agents Chemother. 1996 Oct;40(10):2387-91.

29.

Comparative and collaborative evaluation of standardization of antifungal susceptibility testing for filamentous fungi.

Espinel-Ingroff A, Dawson K, Pfaller M, Anaissie E, Breslin B, Dixon D, Fothergill A, Paetznick V, Peter J, Rinaldi M, et al.

Antimicrob Agents Chemother. 1995 Feb;39(2):314-9.

30.

Correlation between in vitro and in vivo activity of antifungal agents against Candida species.

Anaissie EJ, Karyotakis NC, Hachem R, Dignani MC, Rex JH, Paetznick V.

J Infect Dis. 1994 Aug;170(2):384-9. Erratum in: J Infect Dis 1994 Dec;170(6):1641.

PMID:
8035024
31.

Two-site comparison of broth microdilution and semisolid agar dilution methods for susceptibility testing of Cryptococcus neoformans in three media.

Anaissie E, Shawar R, Paetznick V, Ensign LG, Witte Z, LaRocco M.

J Clin Microbiol. 1993 May;31(5):1370-2.

32.

Collaborative investigation of broth microdilution and semisolid agar dilution for in vitro susceptibility testing of Candida albicans.

Shawar R, Paetznick V, Witte Z, Ensign LG, Anaissie E, LaRocco M.

J Clin Microbiol. 1992 Aug;30(8):1976-81.

33.

Fluconazole susceptibility testing of Candida albicans: microtiter method that is independent of inoculum size, temperature, and time of reading.

Anaissie E, Paetznick V, Bodey GP.

Antimicrob Agents Chemother. 1991 Aug;35(8):1641-6. Erratum in: Antimicrob Agents Chemother 1992 May;36(5):1170.

34.

Comparison of the in vitro antifungal activity of free and liposome-encapsulated amphotericin B.

Anaissie E, Paetznick V, Proffitt R, Adler-Moore J, Bodey GP.

Eur J Clin Microbiol Infect Dis. 1991 Aug;10(8):665-8.

PMID:
1748123

Supplemental Content

Loading ...
Support Center